CRNX

#1321
Crinetics Pharmaceuticals, Inc. - Common Stock
35.5 5 USD
-1.28%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
35.55
35.55
Rango anual
0.36
57.99
Cambio diario
-1.28%
Variación mensual
-7.45%
Variación en los últimos 6 meses
-21.00%
Cambio anual
-13.50%
Cierres anteriores
36.0 1
Open
35.5 5
Mínimo
35.5 5
High
35.5 5
Volumen
148
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 3.75 B
  • Employee 594
  • Founded 2008
  • CEO N/A
  • Website www.crinetics.com
  • Headquarter Delaware, United States
  • FIGI BBG00BC59224
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-9.4
Relación precio/flujo de caja
568.91

Crinetics Pharmaceuticals, Inc. - Common Stock

Crinetics Pharmaceuticals is a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018.

Noticias